Advancement Of Upstream Bioprocess Intensification Through Integration Of Xcell ATF© And Biostat STR© Technologies

At Sartorius, we are proud to collaborate with Repligen in advancing upstream process intensification through the seamless integration of the XCell® ATF Large Scale Controller into our Biostat 3G STR® bioreactor platform. This strategic partnership reflects our commitment to innovation and operational excellence in bioprocessing. By unifying control systems, we have simplified the implementation of intensified seed trains and N perfusion processes, which enables our customers to achieve greater efficiency and scalability in their manufacturing workflows. This integration not only enhances process control and flexibility but also optimizes facility footprint and reduces maintenance demands—key factors in accelerating biotherapeutic production.

Together with Repligen, we are pushing the boundaries of what’s possible in biopharmaceutical manufacturing and empowering our customers to bring life-saving therapies to market faster and more efficiently.